newsfilter
← Latest News
Business Wire·

Bristol-Myers Squibb Provides Update on Pending Transaction with Celgene

NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) today provided an update on its proposed acquisition of Celgene Corporation (NASDAQ:CELG).